Diamond V Receives FDA “Functional Claim” for Dairy DMI

Dairy nutritionists and producers now have more proof of the significant role Diamond V Original Product plays in supporting dry matter intake (DMI) during the early lactation phase. The U.S. Food and Drug Administration (FDA) recently granted Diamond V the functional claim "… helps support the dry matter intake of dairy cows when fed as part of a total mixed ration during the first 70 days of lactation." This makes Diamond V the only company in the category with an FDA accepted functional claim for DMI.

FDA assurance of Diamond V research data builds on the long-standing confidence dairy producers, veterinarians, and nutritionists have in the documented benefits of Original Product in increasing DMI during the critical early lactation phase. Increasing DMI has many benefits for the dairy cow and contributes to greater dairy profitability.

Together, DMI and the diet’s net energy concentration determine the cow’s total energy intake. Because energy intake is the primary driver of milk yield in the first 70 days postpartum, when milk production increases rapidly, the inclusion of Diamond V Original Product in the TMR supports the cow’s metabolic demands when she needs support most.

Increases in DMI during early lactation are associated with:
• Reducing the impact and severity of negative energy balance (NEB) around calving,
• Improved liver function leading to increased availability and conversion of propionate to
glucose, a key driver of milk synthesis,
• Higher peak milks, and
• Increases in total lactation milk production.

Reproduction efficiency improves when energy intake is sufficient during early lactation for:
• Shorter intervals to first ovulation and first estrus,
• Reduced incidence of silent estrus,
• Higher first service conception rates,
• Fewer days open, and
• Shorter calving intervals

Overall cow health benefits profoundly too due to reductions in the incidence of metabolic disease, e.g., milk fever and displaced abomasums, during the critical transition phase. The incidence and severity of the metabolic diseases of early lactation can be reduced by alleviating excessive body fat mobilization through increased DMI.

"Diamond V is committed to bringing products with real, documented value to the dairy industry," says Gerald Poppy, DVM, MBA, Director – North American Dairy. "Diamond V products are properly and fully researched. Too often in our industry, products are sold without employing a peer-reviewed research process. This leaves the dairy producer or dairy professional guessing as to whether or not the products will work as presented. In contrast, Diamond V leads by investing in peer-reviewed research, which can support an application for an FDA functional claim."

About Diamond V
Diamond V, headquartered in Cedar Rapids, Iowa, USA, is the world’s leading supplier of nutritional fermentation products used to optimize digestive function and nutrition key to animal and aqua health, productivity, efficiency, and profitability. Its commitment to innovation, technology and quality has earned Diamond V a global reputation of trust and reliability within the animal feed industry. For more information contact Diamond V at www.diamondv.com.